FDA Approves New Heart Drug by Novartis
Novartis’s genetic drug Levqio was approved by the FDA in December, but hurdles remain for long-term sales. The drug, which [...]
Advertisement
Novartis’s genetic drug Levqio was approved by the FDA in December, but hurdles remain for long-term sales. The drug, which [...]
